IsoPlexis Corporation

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, ABT has a market cap of 177.8B. Regarding current trading prices, ISO is priced at $0.76, while ABT trades at $102.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas ABT's P/E ratio is 27.50. In terms of profitability, ISO's ROE is -1.26%, compared to ABT's ROE of +0.13%. Regarding short-term risk, ISO is more volatile compared to ABT. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check ABT's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, ISO is priced at $0.76, while BSX-PA trades at $122.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, ISO's ROE is -1.26%, compared to BSX-PA's ROE of +0.13%. Regarding short-term risk, ISO is more volatile compared to BSX-PA. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check BSX-PA's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, SYK has a market cap of 127.2B. Regarding current trading prices, ISO is priced at $0.76, while SYK trades at $332.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas SYK's P/E ratio is 39.61. In terms of profitability, ISO's ROE is -1.26%, compared to SYK's ROE of +0.15%. Regarding short-term risk, ISO is more volatile compared to SYK. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check SYK's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, MDT has a market cap of 110.8B. Regarding current trading prices, ISO is priced at $0.76, while MDT trades at $86.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas MDT's P/E ratio is 24.10. In terms of profitability, ISO's ROE is -1.26%, compared to MDT's ROE of +0.10%. Regarding short-term risk, ISO is more volatile compared to MDT. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check MDT's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, BSX has a market cap of 92.9B. Regarding current trading prices, ISO is priced at $0.76, while BSX trades at $62.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas BSX's P/E ratio is 32.26. In terms of profitability, ISO's ROE is -1.26%, compared to BSX's ROE of +0.13%. Regarding short-term risk, ISO is more volatile compared to BSX. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check BSX's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, EW has a market cap of 47.2B. Regarding current trading prices, ISO is priced at $0.76, while EW trades at $81.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas EW's P/E ratio is 44.86. In terms of profitability, ISO's ROE is -1.26%, compared to EW's ROE of +0.10%. Regarding short-term risk, ISO is more volatile compared to EW. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check EW's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, BRKRP has a market cap of 44.2B. Regarding current trading prices, ISO is priced at $0.76, while BRKRP trades at $291.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas BRKRP's P/E ratio is N/A. In terms of profitability, ISO's ROE is -1.26%, compared to BRKRP's ROE of -0.00%. Regarding short-term risk, ISO is more volatile compared to BRKRP. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check BRKRP's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, PHG has a market cap of 26.1B. Regarding current trading prices, ISO is priced at $0.76, while PHG trades at $27.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas PHG's P/E ratio is 25.20. In terms of profitability, ISO's ROE is -1.26%, compared to PHG's ROE of +0.08%. Regarding short-term risk, ISO is more volatile compared to PHG. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check PHG's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, DXCM has a market cap of 24.7B. Regarding current trading prices, ISO is priced at $0.76, while DXCM trades at $63.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas DXCM's P/E ratio is 30.24. In terms of profitability, ISO's ROE is -1.26%, compared to DXCM's ROE of +0.32%. Regarding short-term risk, ISO is more volatile compared to DXCM. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check DXCM's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, STE has a market cap of 21.6B. Regarding current trading prices, ISO is priced at $0.76, while STE trades at $219.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas STE's P/E ratio is 30.68. In terms of profitability, ISO's ROE is -1.26%, compared to STE's ROE of +0.10%. Regarding short-term risk, ISO is more volatile compared to STE. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check STE's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, ZBH has a market cap of 18B. Regarding current trading prices, ISO is priced at $0.76, while ZBH trades at $91.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas ZBH's P/E ratio is 25.64. In terms of profitability, ISO's ROE is -1.26%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, ISO is more volatile compared to ZBH. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check ZBH's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, ISO is priced at $0.76, while ABMD trades at $381.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas ABMD's P/E ratio is 65.36. In terms of profitability, ISO's ROE is -1.26%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, ISO is more volatile compared to ABMD. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check ABMD's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, PODD has a market cap of 14.3B. Regarding current trading prices, ISO is priced at $0.76, while PODD trades at $203.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas PODD's P/E ratio is 58.65. In terms of profitability, ISO's ROE is -1.26%, compared to PODD's ROE of +0.17%. Regarding short-term risk, ISO is more volatile compared to PODD. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check PODD's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, SNN has a market cap of 13.9B. Regarding current trading prices, ISO is priced at $0.76, while SNN trades at $32.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas SNN's P/E ratio is 22.81. In terms of profitability, ISO's ROE is -1.26%, compared to SNN's ROE of +0.12%. Regarding short-term risk, ISO is more volatile compared to SNN. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check SNN's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, PEN has a market cap of 12.9B. Regarding current trading prices, ISO is priced at $0.76, while PEN trades at $329.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas PEN's P/E ratio is 72.83. In terms of profitability, ISO's ROE is -1.26%, compared to PEN's ROE of +0.13%. Regarding short-term risk, ISO is more volatile compared to PEN. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check PEN's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, ISO is priced at $0.76, while SWAV trades at $334.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas SWAV's P/E ratio is 78.76. In terms of profitability, ISO's ROE is -1.26%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, ISO is more volatile compared to SWAV. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check SWAV's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, ALGN has a market cap of 12.3B. Regarding current trading prices, ISO is priced at $0.76, while ALGN trades at $171.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas ALGN's P/E ratio is 30.42. In terms of profitability, ISO's ROE is -1.26%, compared to ALGN's ROE of +0.10%. Regarding short-term risk, ISO is more volatile compared to ALGN. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check ALGN's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, GMED has a market cap of 12B. Regarding current trading prices, ISO is priced at $0.76, while GMED trades at $88.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas GMED's P/E ratio is 22.61. In terms of profitability, ISO's ROE is -1.26%, compared to GMED's ROE of +0.12%. Regarding short-term risk, ISO is more volatile compared to GMED. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check GMED's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, BIO has a market cap of 7.5B. Regarding current trading prices, ISO is priced at $0.76, while BIO trades at $278.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas BIO's P/E ratio is 10.00. In terms of profitability, ISO's ROE is -1.26%, compared to BIO's ROE of +0.11%. Regarding short-term risk, ISO is more volatile compared to BIO. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check BIO's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, BIO-B has a market cap of 7.5B. Regarding current trading prices, ISO is priced at $0.76, while BIO-B trades at $278.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas BIO-B's P/E ratio is 9.99. In terms of profitability, ISO's ROE is -1.26%, compared to BIO-B's ROE of +0.11%. Regarding short-term risk, ISO is more volatile compared to BIO-B. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check BIO-B's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, GKOS has a market cap of 6.8B. Regarding current trading prices, ISO is priced at $0.76, while GKOS trades at $116.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas GKOS's P/E ratio is -35.60. In terms of profitability, ISO's ROE is -1.26%, compared to GKOS's ROE of -0.25%. Regarding short-term risk, ISO is more volatile compared to GKOS. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check GKOS's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, BRKR has a market cap of 5.6B. Regarding current trading prices, ISO is priced at $0.76, while BRKR trades at $36.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas BRKR's P/E ratio is -244.93. In terms of profitability, ISO's ROE is -1.26%, compared to BRKR's ROE of -0.00%. Regarding short-term risk, ISO is more volatile compared to BRKR. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check BRKR's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, ISO is priced at $0.76, while NARI trades at $79.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas NARI's P/E ratio is -59.24. In terms of profitability, ISO's ROE is -1.26%, compared to NARI's ROE of -0.00%. Regarding short-term risk, ISO is more volatile compared to NARI. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check NARI's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, IRTC has a market cap of 3.8B. Regarding current trading prices, ISO is priced at $0.76, while IRTC trades at $117.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas IRTC's P/E ratio is -84.33. In terms of profitability, ISO's ROE is -1.26%, compared to IRTC's ROE of -0.38%. Regarding short-term risk, ISO is more volatile compared to IRTC. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check IRTC's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, ISO is priced at $0.76, while AXNX trades at $70.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas AXNX's P/E ratio is -709.80. In terms of profitability, ISO's ROE is -1.26%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, ISO is more volatile compared to AXNX. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check AXNX's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, TMDX has a market cap of 3.6B. Regarding current trading prices, ISO is priced at $0.76, while TMDX trades at $104.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas TMDX's P/E ratio is 21.51. In terms of profitability, ISO's ROE is -1.26%, compared to TMDX's ROE of +0.54%. Regarding short-term risk, ISO is more volatile compared to TMDX. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check TMDX's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, LIVN has a market cap of 3.5B. Regarding current trading prices, ISO is priced at $0.76, while LIVN trades at $63.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas LIVN's P/E ratio is -14.27. In terms of profitability, ISO's ROE is -1.26%, compared to LIVN's ROE of -0.21%. Regarding short-term risk, ISO is more volatile compared to LIVN. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check LIVN's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, ITGR has a market cap of 3B. Regarding current trading prices, ISO is priced at $0.76, while ITGR trades at $85.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas ITGR's P/E ratio is 29.63. In terms of profitability, ISO's ROE is -1.26%, compared to ITGR's ROE of +0.06%. Regarding short-term risk, ISO is more volatile compared to ITGR. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check ITGR's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, ISO is priced at $0.76, while NUVA trades at $39.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas NUVA's P/E ratio is 75.00. In terms of profitability, ISO's ROE is -1.26%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, ISO is more volatile compared to NUVA. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check NUVA's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, ESTA has a market cap of 1.8B. Regarding current trading prices, ISO is priced at $0.76, while ESTA trades at $60.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas ESTA's P/E ratio is -35.08. In terms of profitability, ISO's ROE is -1.26%, compared to ESTA's ROE of -2.02%. Regarding short-term risk, ISO is more volatile compared to ESTA. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check ESTA's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, AXGN has a market cap of 1.7B. Regarding current trading prices, ISO is priced at $0.76, while AXGN trades at $32.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas AXGN's P/E ratio is -96.00. In terms of profitability, ISO's ROE is -1.26%, compared to AXGN's ROE of -0.13%. Regarding short-term risk, ISO is more volatile compared to AXGN. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check AXGN's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, ATEC has a market cap of 1.7B. Regarding current trading prices, ISO is priced at $0.76, while ATEC trades at $10.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas ATEC's P/E ratio is -11.43. In terms of profitability, ISO's ROE is -1.26%, compared to ATEC's ROE of -17.60%. Regarding short-term risk, ISO is more volatile compared to ATEC. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check ATEC's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, AHCO has a market cap of 1.6B. Regarding current trading prices, ISO is priced at $0.76, while AHCO trades at $12.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas AHCO's P/E ratio is -23.21. In terms of profitability, ISO's ROE is -1.26%, compared to AHCO's ROE of -0.05%. Regarding short-term risk, ISO is more volatile compared to AHCO. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check AHCO's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, AORT has a market cap of 1.6B. Regarding current trading prices, ISO is priced at $0.76, while AORT trades at $33.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas AORT's P/E ratio is 159.38. In terms of profitability, ISO's ROE is -1.26%, compared to AORT's ROE of +0.02%. Regarding short-term risk, ISO is more volatile compared to AORT. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check AORT's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, INSP has a market cap of 1.6B. Regarding current trading prices, ISO is priced at $0.76, while INSP trades at $54.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas INSP's P/E ratio is 11.06. In terms of profitability, ISO's ROE is -1.26%, compared to INSP's ROE of +0.21%. Regarding short-term risk, ISO is more volatile compared to INSP. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check INSP's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, PMI has a market cap of 1.5B. Regarding current trading prices, ISO is priced at $0.76, while PMI trades at $0.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas PMI's P/E ratio is -1.30. In terms of profitability, ISO's ROE is -1.26%, compared to PMI's ROE of +2.17%. Regarding short-term risk, ISO is more volatile compared to PMI. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check PMI's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, UFPT has a market cap of 1.5B. Regarding current trading prices, ISO is priced at $0.76, while UFPT trades at $192.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas UFPT's P/E ratio is 21.94. In terms of profitability, ISO's ROE is -1.26%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, ISO is more volatile compared to UFPT. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check UFPT's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, PRCT has a market cap of 1.3B. Regarding current trading prices, ISO is priced at $0.76, while PRCT trades at $23.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas PRCT's P/E ratio is -13.83. In terms of profitability, ISO's ROE is -1.26%, compared to PRCT's ROE of -0.25%. Regarding short-term risk, ISO is more volatile compared to PRCT. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check PRCT's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, TNDM has a market cap of 1.3B. Regarding current trading prices, ISO is priced at $0.76, while TNDM trades at $19.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas TNDM's P/E ratio is -6.31. In terms of profitability, ISO's ROE is -1.26%, compared to TNDM's ROE of -1.42%. Regarding short-term risk, ISO is more volatile compared to TNDM. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check TNDM's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, ISO is priced at $0.76, while HSKA trades at $119.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas HSKA's P/E ratio is -62.49. In terms of profitability, ISO's ROE is -1.26%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, ISO is more volatile compared to HSKA. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check HSKA's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, IRMD has a market cap of 1.2B. Regarding current trading prices, ISO is priced at $0.76, while IRMD trades at $95.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas IRMD's P/E ratio is 54.66. In terms of profitability, ISO's ROE is -1.26%, compared to IRMD's ROE of +0.24%. Regarding short-term risk, ISO is more volatile compared to IRMD. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check IRMD's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, ISO is priced at $0.76, while SILK trades at $27.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas SILK's P/E ratio is -18.96. In terms of profitability, ISO's ROE is -1.26%, compared to SILK's ROE of -0.35%. Regarding short-term risk, ISO is more volatile compared to SILK. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check SILK's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, ISO is priced at $0.76, while FNA trades at $13.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas FNA's P/E ratio is -19.83. In terms of profitability, ISO's ROE is -1.26%, compared to FNA's ROE of -0.35%. Regarding short-term risk, ISO is more volatile compared to FNA. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check FNA's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, CNMD has a market cap of 1.1B. Regarding current trading prices, ISO is priced at $0.76, while CNMD trades at $34.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas CNMD's P/E ratio is 22.58. In terms of profitability, ISO's ROE is -1.26%, compared to CNMD's ROE of +0.05%. Regarding short-term risk, ISO is more volatile compared to CNMD. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check CNMD's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, BFLY has a market cap of 1.1B. Regarding current trading prices, ISO is priced at $0.76, while BFLY trades at $4.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas BFLY's P/E ratio is -13.35. In terms of profitability, ISO's ROE is -1.26%, compared to BFLY's ROE of -0.35%. Regarding short-term risk, ISO is more volatile compared to BFLY. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check BFLY's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, SSII has a market cap of 934.9M. Regarding current trading prices, ISO is priced at $0.76, while SSII trades at $4.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas SSII's P/E ratio is -80.17. In terms of profitability, ISO's ROE is -1.26%, compared to SSII's ROE of -0.30%. Regarding short-term risk, ISO is more volatile compared to SSII. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check SSII's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, INMD has a market cap of 868.6M. Regarding current trading prices, ISO is priced at $0.76, while INMD trades at $13.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas INMD's P/E ratio is 9.59. In terms of profitability, ISO's ROE is -1.26%, compared to INMD's ROE of +0.15%. Regarding short-term risk, ISO is more volatile compared to INMD. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check INMD's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, LMRI has a market cap of 845.4M. Regarding current trading prices, ISO is priced at $0.76, while LMRI trades at $8.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas LMRI's P/E ratio is -13.55. In terms of profitability, ISO's ROE is -1.26%, compared to LMRI's ROE of -0.18%. Regarding short-term risk, ISO is more volatile compared to LMRI. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check LMRI's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, ISO is priced at $0.76, while CSII trades at $20.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas CSII's P/E ratio is -20.83. In terms of profitability, ISO's ROE is -1.26%, compared to CSII's ROE of -0.14%. Regarding short-term risk, ISO is more volatile compared to CSII. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check CSII's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, IART has a market cap of 725.6M. Regarding current trading prices, ISO is priced at $0.76, while IART trades at $9.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas IART's P/E ratio is -1.38. In terms of profitability, ISO's ROE is -1.26%, compared to IART's ROE of -0.44%. Regarding short-term risk, ISO is more volatile compared to IART. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check IART's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, CRY has a market cap of 725.1M. Regarding current trading prices, ISO is priced at $0.76, while CRY trades at $17.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas CRY's P/E ratio is 425.71. In terms of profitability, ISO's ROE is -1.26%, compared to CRY's ROE of +0.02%. Regarding short-term risk, ISO is more volatile compared to CRY. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check CRY's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, CBLL has a market cap of 683.9M. Regarding current trading prices, ISO is priced at $0.76, while CBLL trades at $18.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas CBLL's P/E ratio is -12.45. In terms of profitability, ISO's ROE is -1.26%, compared to CBLL's ROE of -0.32%. Regarding short-term risk, ISO is more volatile compared to CBLL. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check CBLL's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, AVNS has a market cap of 643.1M. Regarding current trading prices, ISO is priced at $0.76, while AVNS trades at $13.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas AVNS's P/E ratio is -8.81. In terms of profitability, ISO's ROE is -1.26%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, ISO is more volatile compared to AVNS. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check AVNS's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, ISO is priced at $0.76, while SRDX trades at $42.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas SRDX's P/E ratio is -34.66. In terms of profitability, ISO's ROE is -1.26%, compared to SRDX's ROE of -0.13%. Regarding short-term risk, ISO is more volatile compared to SRDX. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check SRDX's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, BVS has a market cap of 607.7M. Regarding current trading prices, ISO is priced at $0.76, while BVS trades at $9.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas BVS's P/E ratio is 27.33. In terms of profitability, ISO's ROE is -1.26%, compared to BVS's ROE of +0.14%. Regarding short-term risk, ISO is more volatile compared to BVS. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check BVS's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, SIBN has a market cap of 583.4M. Regarding current trading prices, ISO is priced at $0.76, while SIBN trades at $13.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas SIBN's P/E ratio is -30.02. In terms of profitability, ISO's ROE is -1.26%, compared to SIBN's ROE of -0.11%. Regarding short-term risk, ISO is more volatile compared to SIBN. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check SIBN's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, CTKB has a market cap of 581M. Regarding current trading prices, ISO is priced at $0.76, while CTKB trades at $4.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas CTKB's P/E ratio is -8.69. In terms of profitability, ISO's ROE is -1.26%, compared to CTKB's ROE of -0.18%. Regarding short-term risk, ISO is more volatile compared to CTKB. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check CTKB's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, ISO is priced at $0.76, while APEN trades at $10.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas APEN's P/E ratio is -9.43. In terms of profitability, ISO's ROE is -1.26%, compared to APEN's ROE of -0.85%. Regarding short-term risk, ISO is more volatile compared to APEN. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check APEN's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, TCMD has a market cap of 559M. Regarding current trading prices, ISO is priced at $0.76, while TCMD trades at $24.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas TCMD's P/E ratio is 29.96. In terms of profitability, ISO's ROE is -1.26%, compared to TCMD's ROE of +0.09%. Regarding short-term risk, ISO is more volatile compared to TCMD. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check TCMD's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, ISO is priced at $0.76, while ZIMV trades at $18.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, ISO's ROE is -1.26%, compared to ZIMV's ROE of -0.04%. Regarding short-term risk, ISO is more volatile compared to ZIMV. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check ZIMV's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, BWAY has a market cap of 493.4M. Regarding current trading prices, ISO is priced at $0.76, while BWAY trades at $12.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas BWAY's P/E ratio is 69.89. In terms of profitability, ISO's ROE is -1.26%, compared to BWAY's ROE of +0.11%. Regarding short-term risk, ISO is more volatile compared to BWAY. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check BWAY's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, NPCE has a market cap of 491.5M. Regarding current trading prices, ISO is priced at $0.76, while NPCE trades at $14.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas NPCE's P/E ratio is -22.12. In terms of profitability, ISO's ROE is -1.26%, compared to NPCE's ROE of -1.06%. Regarding short-term risk, ISO is more volatile compared to NPCE. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check NPCE's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, OFIX has a market cap of 472.5M. Regarding current trading prices, ISO is priced at $0.76, while OFIX trades at $11.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas OFIX's P/E ratio is -5.05. In terms of profitability, ISO's ROE is -1.26%, compared to OFIX's ROE of -0.20%. Regarding short-term risk, ISO is more volatile compared to OFIX. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check OFIX's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, VREX has a market cap of 442.7M. Regarding current trading prices, ISO is priced at $0.76, while VREX trades at $10.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas VREX's P/E ratio is -6.44. In terms of profitability, ISO's ROE is -1.26%, compared to VREX's ROE of -0.14%. Regarding short-term risk, ISO is more volatile compared to VREX. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check VREX's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, PACB has a market cap of 428.8M. Regarding current trading prices, ISO is priced at $0.76, while PACB trades at $1.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas PACB's P/E ratio is -0.78. In terms of profitability, ISO's ROE is -1.26%, compared to PACB's ROE of -11.23%. Regarding short-term risk, ISO is more volatile compared to PACB. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check PACB's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, KIDS has a market cap of 402.9M. Regarding current trading prices, ISO is priced at $0.76, while KIDS trades at $15.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas KIDS's P/E ratio is -9.54. In terms of profitability, ISO's ROE is -1.26%, compared to KIDS's ROE of -0.11%. Regarding short-term risk, ISO is more volatile compared to KIDS. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check KIDS's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, VMD has a market cap of 376.8M. Regarding current trading prices, ISO is priced at $0.76, while VMD trades at $9.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas VMD's P/E ratio is 26.38. In terms of profitability, ISO's ROE is -1.26%, compared to VMD's ROE of +0.11%. Regarding short-term risk, ISO is more volatile compared to VMD. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check VMD's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, CERS has a market cap of 355.5M. Regarding current trading prices, ISO is priced at $0.76, while CERS trades at $1.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas CERS's P/E ratio is -23.12. In terms of profitability, ISO's ROE is -1.26%, compared to CERS's ROE of -0.26%. Regarding short-term risk, ISO is more volatile compared to CERS. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check CERS's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, LAB has a market cap of 347.2M. Regarding current trading prices, ISO is priced at $0.76, while LAB trades at $0.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas LAB's P/E ratio is -5.93. In terms of profitability, ISO's ROE is -1.26%, compared to LAB's ROE of -0.18%. Regarding short-term risk, ISO is more volatile compared to LAB. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check LAB's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, DCTH has a market cap of 337M. Regarding current trading prices, ISO is priced at $0.76, while DCTH trades at $9.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas DCTH's P/E ratio is 138.57. In terms of profitability, ISO's ROE is -1.26%, compared to DCTH's ROE of +0.03%. Regarding short-term risk, ISO is more volatile compared to DCTH. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check DCTH's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, CATX has a market cap of 323M. Regarding current trading prices, ISO is priced at $0.76, while CATX trades at $4.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas CATX's P/E ratio is -3.11. In terms of profitability, ISO's ROE is -1.26%, compared to CATX's ROE of -0.41%. Regarding short-term risk, ISO is more volatile compared to CATX. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check CATX's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, ISO is priced at $0.76, while SMLR trades at $20.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas SMLR's P/E ratio is 3.92. In terms of profitability, ISO's ROE is -1.26%, compared to SMLR's ROE of +0.16%. Regarding short-term risk, ISO is more volatile compared to SMLR. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check SMLR's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, RXST has a market cap of 289.7M. Regarding current trading prices, ISO is priced at $0.76, while RXST trades at $7.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas RXST's P/E ratio is -7.39. In terms of profitability, ISO's ROE is -1.26%, compared to RXST's ROE of -0.14%. Regarding short-term risk, ISO is more volatile compared to RXST. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check RXST's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, SENS has a market cap of 279.4M. Regarding current trading prices, ISO is priced at $0.76, while SENS trades at $6.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas SENS's P/E ratio is -4.03. In terms of profitability, ISO's ROE is -1.26%, compared to SENS's ROE of -1.04%. Regarding short-term risk, ISO is more volatile compared to SENS. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check SENS's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, CLPT has a market cap of 279M. Regarding current trading prices, ISO is priced at $0.76, while CLPT trades at $9.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas CLPT's P/E ratio is -10.42. In terms of profitability, ISO's ROE is -1.26%, compared to CLPT's ROE of -1.22%. Regarding short-term risk, ISO is more volatile compared to CLPT. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check CLPT's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, MASS has a market cap of 256.1M. Regarding current trading prices, ISO is priced at $0.76, while MASS trades at $6.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas MASS's P/E ratio is -7.37. In terms of profitability, ISO's ROE is -1.26%, compared to MASS's ROE of +0.13%. Regarding short-term risk, ISO is more volatile compared to MASS. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check MASS's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, ISO is priced at $0.76, while MGRM trades at $6.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas MGRM's P/E ratio is -11.11. In terms of profitability, ISO's ROE is -1.26%, compared to MGRM's ROE of -1.11%. Regarding short-term risk, ISO is more volatile compared to MGRM. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check MGRM's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, CVRX has a market cap of 238.1M. Regarding current trading prices, ISO is priced at $0.76, while CVRX trades at $9.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas CVRX's P/E ratio is -4.44. In terms of profitability, ISO's ROE is -1.26%, compared to CVRX's ROE of -0.99%. Regarding short-term risk, ISO is more volatile compared to CVRX. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check CVRX's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, ISO is priced at $0.76, while NVRO trades at $5.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas NVRO's P/E ratio is -1.91. In terms of profitability, ISO's ROE is -1.26%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, ISO is more volatile compared to NVRO. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check NVRO's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, ANIK has a market cap of 212.7M. Regarding current trading prices, ISO is priced at $0.76, while ANIK trades at $14.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas ANIK's P/E ratio is -21.07. In terms of profitability, ISO's ROE is -1.26%, compared to ANIK's ROE of -0.07%. Regarding short-term risk, ISO is more volatile compared to ANIK. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check ANIK's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, EYES has a market cap of 210M. Regarding current trading prices, ISO is priced at $0.76, while EYES trades at $4.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas EYES's P/E ratio is N/A. In terms of profitability, ISO's ROE is -1.26%, compared to EYES's ROE of -3.17%. Regarding short-term risk, ISO is more volatile compared to EYES. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check EYES's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, PROF has a market cap of 198.5M. Regarding current trading prices, ISO is priced at $0.76, while PROF trades at $6.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas PROF's P/E ratio is -4.65. In terms of profitability, ISO's ROE is -1.26%, compared to PROF's ROE of -0.80%. Regarding short-term risk, ISO is more volatile compared to PROF. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check PROF's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, ELMD has a market cap of 196M. Regarding current trading prices, ISO is priced at $0.76, while ELMD trades at $23.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas ELMD's P/E ratio is 22.82. In terms of profitability, ISO's ROE is -1.26%, compared to ELMD's ROE of +0.20%. Regarding short-term risk, ISO is more volatile compared to ELMD. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check ELMD's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, SGHT has a market cap of 191.7M. Regarding current trading prices, ISO is priced at $0.76, while SGHT trades at $3.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas SGHT's P/E ratio is -4.80. In terms of profitability, ISO's ROE is -1.26%, compared to SGHT's ROE of -0.56%. Regarding short-term risk, ISO is more volatile compared to SGHT. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check SGHT's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, ISO is priced at $0.76, while BSGM trades at $6.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas BSGM's P/E ratio is -5.81. In terms of profitability, ISO's ROE is -1.26%, compared to BSGM's ROE of +17.60%. Regarding short-term risk, ISO is less volatile compared to BSGM. This indicates potentially lower risk in terms of short-term price fluctuations for ISO.Check BSGM's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, AVR has a market cap of 189.8M. Regarding current trading prices, ISO is priced at $0.76, while AVR trades at $5.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas AVR's P/E ratio is -2.02. In terms of profitability, ISO's ROE is -1.26%, compared to AVR's ROE of -5.28%. Regarding short-term risk, ISO is more volatile compared to AVR. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check AVR's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, QTI has a market cap of 179.4M. Regarding current trading prices, ISO is priced at $0.76, while QTI trades at $6.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas QTI's P/E ratio is -3.29. In terms of profitability, ISO's ROE is -1.26%, compared to QTI's ROE of +3.64%. Regarding short-term risk, ISO is more volatile compared to QTI. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check QTI's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, ISO is priced at $0.76, while MDGS trades at $2.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas MDGS's P/E ratio is -0.27. In terms of profitability, ISO's ROE is -1.26%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, ISO is more volatile compared to MDGS. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check MDGS's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, INGN has a market cap of 173.2M. Regarding current trading prices, ISO is priced at $0.76, while INGN trades at $6.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas INGN's P/E ratio is -7.40. In terms of profitability, ISO's ROE is -1.26%, compared to INGN's ROE of -0.12%. Regarding short-term risk, ISO is more volatile compared to INGN. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check INGN's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, QTRX has a market cap of 169M. Regarding current trading prices, ISO is priced at $0.76, while QTRX trades at $3.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas QTRX's P/E ratio is -1.43. In terms of profitability, ISO's ROE is -1.26%, compared to QTRX's ROE of -0.35%. Regarding short-term risk, ISO is more volatile compared to QTRX. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check QTRX's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, ISO is priced at $0.76, while QIPT trades at $3.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas QIPT's P/E ratio is -15.87. In terms of profitability, ISO's ROE is -1.26%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, ISO is more volatile compared to QIPT. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check QIPT's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, APYX has a market cap of 157.3M. Regarding current trading prices, ISO is priced at $0.76, while APYX trades at $3.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas APYX's P/E ratio is -13.93. In terms of profitability, ISO's ROE is -1.26%, compared to APYX's ROE of -1.18%. Regarding short-term risk, ISO is more volatile compared to APYX. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check APYX's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, TLSI has a market cap of 154.7M. Regarding current trading prices, ISO is priced at $0.76, while TLSI trades at $4.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas TLSI's P/E ratio is -2.22. In terms of profitability, ISO's ROE is -1.26%, compared to TLSI's ROE of +1.37%. Regarding short-term risk, ISO is more volatile compared to TLSI. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check TLSI's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, NNOX has a market cap of 151.1M. Regarding current trading prices, ISO is priced at $0.76, while NNOX trades at $2.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas NNOX's P/E ratio is -2.69. In terms of profitability, ISO's ROE is -1.26%, compared to NNOX's ROE of -0.32%. Regarding short-term risk, ISO is more volatile compared to NNOX. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check NNOX's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, SNWV has a market cap of 147M. Regarding current trading prices, ISO is priced at $0.76, while SNWV trades at $17.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas SNWV's P/E ratio is 41.73. In terms of profitability, ISO's ROE is -1.26%, compared to SNWV's ROE of -1.42%. Regarding short-term risk, ISO is more volatile compared to SNWV. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check SNWV's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, EDAP has a market cap of 129.7M. Regarding current trading prices, ISO is priced at $0.76, while EDAP trades at $3.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas EDAP's P/E ratio is -4.44. In terms of profitability, ISO's ROE is -1.26%, compared to EDAP's ROE of -1.15%. Regarding short-term risk, ISO is more volatile compared to EDAP. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check EDAP's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, LUCD has a market cap of 115.6M. Regarding current trading prices, ISO is priced at $0.76, while LUCD trades at $1.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas LUCD's P/E ratio is -1.64. In terms of profitability, ISO's ROE is -1.26%, compared to LUCD's ROE of -5.91%. Regarding short-term risk, ISO is more volatile compared to LUCD. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check LUCD's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, FONR has a market cap of 114.8M. Regarding current trading prices, ISO is priced at $0.76, while FONR trades at $18.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas FONR's P/E ratio is 16.17. In terms of profitability, ISO's ROE is -1.26%, compared to FONR's ROE of +0.04%. Regarding short-term risk, ISO is more volatile compared to FONR. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check FONR's competition here

ISO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISO stands at 30.3M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, ISO is priced at $0.76, while ICAD trades at $3.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISO currently has a P/E ratio of -0.30, whereas ICAD's P/E ratio is -20.37. In terms of profitability, ISO's ROE is -1.26%, compared to ICAD's ROE of -0.06%. Regarding short-term risk, ISO is more volatile compared to ICAD. This indicates potentially higher risk in terms of short-term price fluctuations for ISO.Check ICAD's competition here